US Merger & Acquisition SEC Filings — August 21, 2026

21-08-2026

Liberty Broadband Corp filed an 8-K on August 21, 2026, reporting the termination of a material agreement and the adoption of new bylaws for a wholly owned subsidiary, Fusion Merger Sub 2, Inc., indicating an upcoming merger or acquisition. The filing includes standard corporate governance provisions for the merger subsidiary but provides no financial details or performance metrics.

• · The filing includes Items 1.02 (Termination of a Material Agreement), 2.01 (Completion of Acquisition or Disposition of Assets), 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule), 3.03 (Material Modification to Rights of Security Holders), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits).
• · The bylaws establish the registered office at 251 Little Falls Drive, Wilmington, Delaware, with Corporation Service Company as registered agent.
• · The board of directors initially consists of one person and may be fixed thereafter by the board.
• · Stockholder meetings require a majority of voting power for a quorum; directors are elected by plurality vote.

21-08-2026

Bleichroeder Acquisition Corp. II entered into an amended advisory services agreement with MJP Advisory Group LLC, an affiliate of CEO Marcello Padula, on August 19, 2026. The agreement provides for a monthly fee of $18,000, a one-time closing fee of $1,850,000 upon completion of an initial business combination (the Pasqal Business Combination), or a liquidation fee of $600,000 if the company liquidates. No payments may be made from the trust account for public shareholders.

• · The A&R Agreement was approved by the Board of Directors on August 19, 2026.
• · Mr. Padula's appointment as CEO was effective April 29, 2026.
• · The Pasqal Business Combination Agreement was dated February 28, 2026, and involves Bleichroeder Acquisition France Merger Sub 2 and Pasqal Holding SAS.
• · If the company terminates without cause, MJP receives monthly fees for an additional six months (or until business combination, whichever is shorter) plus the applicable closing/liquidation fee.
• · No payments may be made from the trust account for public shareholders.

21-08-2026

JAB Acquisition Corp I entered into a trademark settlement agreement on August 17, 2026, to resolve a claim regarding its name and trading symbol. As a result, the company plans to change its ticker symbols to ATLQ, ATLQU, ATLQW, and ATLQR and intends to rename itself Atlantic Acquisition Corp I, subject to board and shareholder approval. No action is required from shareholders, and the capital structure remains unchanged.

• · The settlement was with an unnamed third party (Claimant) to resolve an outstanding trademark claim.
• · New ticker symbols are expected to be ATLQ (ordinary shares), ATLQU (units), ATLQW (warrants), and ATLQR (rights).
• · Name change to Atlantic Acquisition Corp I requires both board and shareholder approval.
• · The company's CIK number will remain unchanged after the ticker change.

21-08-2026

The filing reports the completion of an acquisition by RocketFuel Blockchain, Inc. on August 21, 2026, under Item 2.01 of Form 8-K. However, the filing does not disclose the target company, deal size, consideration type, or any financial metrics. Without these critical details, the transaction cannot be evaluated for strategic rationale, valuation, or shareholder impact.

21-08-2026

Elutia completed the sale of its SimpliDerm business to Cellution Biologics for up to $11 million, receiving $8 million at closing and up to $3 million in milestone payments over 18 months. The divestiture adds non-dilutive capital to fund the development and commercial launch of NXT-41x, an antibiotic-eluting biomatrix targeting the $1.5 billion U.S. plastic and reconstructive surgery market. However, the company remains dependent on a narrower product set and faces risks from regulatory clearance (expected first half of 2027) and commercial execution.

• · NXT-41x is designed to provide soft-tissue reinforcement while locally delivering antibiotics to inhibit bacterial colonization at the surgical site.
• · Elutia plans to first commercialize NXT-41x in plastic/reconstructive surgery, then expand into general and oncologic surgeries.
• · The company believes it has sufficient funding to support operations through the first full year of NXT-41x commercial launch in 2028.
• · The sale was led by Dr. Sonali Fonseca, Vice President of Emerging Business.

21-08-2026

K&F Growth Acquisition Corp. II received a Nasdaq deficiency notice on August 19, 2026, for failing to meet the minimum 400 total holders requirement for continued listing on the Nasdaq Global Market. The company has 45 days to submit a compliance plan and may be granted up to 180 days to cure the deficiency, or it may consider transferring to the Nasdaq Capital Market. The notice does not currently affect trading, and shares continue to trade under the symbol KFII.

• · The company has 45 calendar days from August 19, 2026 to submit a plan to regain compliance.
• · If Nasdaq accepts the plan, an extension of up to 180 calendar days may be granted.
• · The company may alternatively apply to transfer its securities to the Nasdaq Capital Market.
• · The company is an emerging growth company and has not elected to use the extended transition period for new financial accounting standards.

21-08-2026

Meridian3 Industrials Acquisition Corp announced that holders of its units may elect to separately trade the Class A ordinary shares and warrants starting August 24, 2026. The units were issued in the company's initial public offering and each unit consists of one Class A ordinary share and one-half of one redeemable warrant. No financial results or performance metrics were disclosed in this filing.

• · Separate trading begins on August 24, 2026.
• · Units not separated will continue to trade under symbol MIACU on Nasdaq Global Market.
• · Separated Class A ordinary shares will trade under symbol MIAC, and warrants under MIACW.
• · No fractional warrants will be issued; only whole warrants will trade.
• · Holders must contact Continental Stock Transfer & Trust Company through their brokers to separate units.

21-08-2026

Breeze Acquisition Corp. II (BREZ) received a Nasdaq deficiency notice on August 20, 2026, for failing to file its Q1 2026 and Q2 2026 Form 10-Qs on time, violating Nasdaq Listing Rule 5250(c)(1). The company has 30 days (until September 21, 2026) to submit a compliance plan; if accepted, Nasdaq may grant an exception until December 28, 2026. While the notice has no immediate effect on trading, the company faces potential delisting if it fails to regain compliance, and there is no assurance the plan will be accepted or that the company can meet the conditions of any exception.

• · The company is a blank check (SPAC) incorporated in the Cayman Islands.
• · The company's securities trade on Nasdaq under symbols BREZ (ordinary shares) and BREZR (rights).
• · If the compliance plan is not accepted, the company can appeal to a Nasdaq Hearings Panel.
• · Any subsequent periodic filing due within the 180-day exception period must be filed no later than the end of that period.